Study of Molecular Docking, Physicochemical and Pharmacokinetic Properties of GSK-3β Inhibitors

Journal Title: Journal of Pharmaceutical Research International - Year 2015, Vol 7, Issue 3

Abstract

Aims: Alzheimer disease (AD) affects people aged 65 to 90 years and is the most prevalent neurodegenerative disease in the world. The deposition of β-amyloid peptide forming the amyloid plaques as well as neurofibrillary tangles deposition due to hyperphosphorylation of tau protein are the major cause of the disease in addition to the deficit of the neurotransmitter acetylcholine in the synaptic gap. Among the treatments for AD are acetylcholinesterase, beta-secretase and Glycogen Synthase Kinase-3β (GSK-3β) inhibitors. GSK-3β has been associated with all primary abnormalities of AD, because it interacts with the different components of the amyloid plaques production system and participates in the phosphorylation of tau protein. This regulates and stabilizes the microtubules in axons of the neurons of the Central Nervous System (CNS). The present study aimed to propose three novel candidates for inhibitors of GSK-3β. Place and Duration of Study: Laboratory of Modeling and Computational Chemistry (LMCC) at Federal University of Amapá (UNIFAP), Macapá, Brazil, between November 2014 and March 2015. Methodology: First, we used the crystal structure of GSK-3β enzyme deposited in the the Protein Data Bank (PDB) (PDB ID: 3Q3B – at 2.7 Å resolution). Then, we selected 50 inhibitors reported and available in the database BindingDB. Docking simulations were subsequently carried out using the AutoDock Vina 1.5.6 software. In sequence, a pharmacophore perception calculation was performed as well as and pharmacokinetic properties calculations. Finally, new proposals of GSK-3β inhibitors candidates were designed, considering in addition potential biological activity and synthetic accessibility as well as. Results: In the study of physical and chemical parameters, most of the compounds violated no more than two parameters of the Lipinski’s Rule of five, indicating suitable oral absorption. Along of the docking simulations, 22 inhibitors showed strong interaction with the amino acid residues of the enzyme active site (hydrogen bond and hydrophobic interactions). Along of the pharmacophore perception calculation, 30 molecules lined up with four pharmacophore points: two aromatic rings and two hydrogen bond acceptor groups (in the case, pyrimidine group). Along the prediction of pharmacokinetics, the most of the potential GSK-3β inhibitors showed good permeability of Caco2 and MDCK cells, high absorption in the human intestine and weak binding to plasma proteins, but only two ones showed absorption in the blood brain barrier. The three proposals of GSK-3β inhibitor candidates indicate biological activity for GSK-3β, as well as having average synthetic accessibility. Conclusion: This current study reveals three new promising compounds with in silico GSK-3β inhibitory activity. Therefore, further studies of quantitative structure-activity relationship as are necessary to investigate how the chemical structures of these molecules affect their biological potency and binding affinity for GSK-3β enzyme, and thus, selecting potential drug candidates for synthesis and biological testing.

Authors and Affiliations

Leide C. S. Picanço, Leandro L. Castro, Abraão A. Pinheiro, Karina R. da Silva, Lucilene R. de Souza, Francinaldo S. Braga, Carlos H. T. P. da Silva, Cleydson B. R. Santos, Lorane I. S. Hage-Melim

Keywords

Related Articles

Higher Haemoglobin Level Variation under Treatment with Erythropoitin is Associated with Mortality in Haemodialysis

Background: During recent years therapy with erythropoesis stimulating agents (ESA) in chronic kidney disease necessitating dialysis (CKD5D) has been challenged following worse study outcome in patients exceeding upper h...

Gene Expression Profiling of Triple Negative Breast Cancer Cells Treated with Afatinib

Purpose: To investigate gene expression profile changes in triple negative breast cancer cells (MDA-MB-231) treated with afatinib. Methods: Differential expression of 84 genes commonly involved in breast cancer carcinog...

Thyrotoxic Evaluation and Lipid Peroxidation in Wistar Albino Rats Exposed to Vitellaria paradoxa Stem Bark

Background: Vitellaria paradoxa stem bark is used by villagers because of its antimicrobial activity for treating skin diseases and wound infections in some parts of Nigeria without considering its safety. Aim: The aim o...

Pharmaceutical and Analytical Evaluation of Prolonged Release Rosuvastatin-Ca Buccoadhesive Tablets

Rosuvastatin-Ca was prepared in solid dispersion as buccoadhesive tablets to increase its bioavailability and the release of the drug from its buccoadhesive formulae due to its poor aqueous solubility. The solid dispersi...

Antimicrobial, Antioxidant and Anticancer Activities of Turnera ulmifolia (Yellow Alder) Callus

Aim: The current work aims to study the effect of ethanolic and methanolic extracts of Turnera ulmifolia callus on antimicrobial, antioxidant and anticancer activities. Study Design: The Five grams of leaf derived 30 day...

Download PDF file
  • EP ID EP344389
  • DOI 10.9734/BJPR/2015/18054
  • Views 93
  • Downloads 0

How To Cite

Leide C. S. Picanço, Leandro L. Castro, Abraão A. Pinheiro, Karina R. da Silva, Lucilene R. de Souza, Francinaldo S. Braga, Carlos H. T. P. da Silva, Cleydson B. R. Santos, Lorane I. S. Hage-Melim (2015). Study of Molecular Docking, Physicochemical and Pharmacokinetic Properties of GSK-3β Inhibitors. Journal of Pharmaceutical Research International, 7(3), 152-175. https://europub.co.uk./articles/-A-344389